Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple endogenous zinc-binding proteins and enzymes represent a broad category of biological molecules that utilize zinc (Zn2+) as a critical structural or catalytic cofactor. It is estimated that nearly 10% of the human proteome, involving over 3,000 proteins, requires zinc for proper function (Andreini et al., J. Proteome Res. 2006). This group includes major enzyme classes such as carbonic anhydrases, matrix metalloproteinases, and alcohol dehydrogenases, which are essential for pH regulation, tissue remodeling, and metabolism respectively (Vallee & Auld, Biochemistry 1990). Additionally, zinc finger motifs are the most common DNA-binding structures in human transcription factors, making zinc indispensable for gene expression and cellular differentiation (Klug, Annu. Rev. Biochem. 2010). Pharmacologically, this collective group is relevant in the treatment of Wilson's disease, where zinc salts (e.g., zinc acetate) induce the endogenous protein metallothionein to sequester copper and prevent its absorption (NIH, 2022). Because this "target" is a heterogeneous collection of essential proteins rather than a single entity, it is often cited in drug databases to describe the broad-spectrum effects of metal-based therapies or chelators. Therapeutic intervention targeting this group must be carefully managed to avoid systemic toxicity or secondary mineral deficiencies, such as copper depletion.
The primary mechanisms include the induction of metallothionein in the intestinal mucosa to inhibit copper absorption, the direct chelation of zinc ions to remove them from the body, and the provision of exogenous zinc to restore the function of zinc-dependent enzymes in deficiency states.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple endogenous zinc-binding proteins and enzymes.